Phosphodiesterase 5 Inhibitors from Derris scandens

被引:9
作者
Chaichamnong, Nattiya [1 ]
Temkitthawon, Prapapan [1 ]
Khorana, Nantaka [1 ]
Pitpakdeeanan, Prompan [1 ]
Taepavarapruk, Pornnarin [2 ,3 ]
Nuengchamnong, Nitra [4 ]
Siriwattanasathien, Yuthana [5 ]
Suksamrarn, Apichart [5 ]
Ingkaninan, Kornkanok [1 ]
机构
[1] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem & Pharmacognosy, Bioscreening Unit, Nakhon Sawan Rd, Phitsanulok 65000, Thailand
[2] Naresuan Univ, Fac Med Sci, Ctr Anim Res, Phitsanulok, Thailand
[3] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand
[4] Naresuan Univ, Fac Sci, Sci Lab Ctr, Phitsanulok, Thailand
[5] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok, Thailand
关键词
Derris scandens; Fabaceae; phosphodiesterase; 5; erectile dysfunction; isoflavoner; LC-QTOF-MS; DERIVATIVES; POTENT;
D O I
10.1055/a-0619-5547
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Phosphodiesterase 5 inhibitors have been used as a first-line medicine for the treatment of erectile dysfunction. In the search for new phosphodiesterase 5 inhibitors from natural sources, we found that the 95% ethanol extract of Derris scandens stem showed phosphodiesterase 5 inhibitory activity with an IC50 value of about 7 mu g/mL. Seven isoflavones and a coumarin constituent isolated from this plant were investigated for phosphodiesterase 5 inhibitory activity. The results showed that osajin (8), 4', 5,7-trihydroxybiprenylisoflavone (4), and derrisisoflavone A (2) had the ability to inhibit phosphodiesterase 5 with IC50 values of 4, 8, and 9 mu M, respectively. These compounds exhibited selectivity on phosphodiesterase 5 over phosphodiesterase 1, however, the selectivity on phosphodiesterase 5 over phosphodiesterase 6 was low. In order to quantitatively determine these bioactive constituents in D. scandens extract, LC-QTOF-MS method has been developed and validated. The limit of quantitation values in the range of 0.1-5 mu g/mL were obtained. The assay showed satisfactory precision and accuracy. The results from our method showed that the 95% ethanol extract of D. scandens stem was comprised of all eight compounds, with derrisisoflavone A (2) and lupalbigenin (3) presenting as the major constituents.
引用
收藏
页码:1134 / 1140
页数:7
相关论文
共 29 条
[1]  
Beavo J A, 2007, PHOSPHODIESTERASE 5, P131
[2]   Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use [J].
Bender, Andrew T. ;
Beavo, Joseph A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :488-520
[3]   Potency, selectivity, and consequences of nonselectivity of PDE inhibition [J].
Bischoff, E .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) :S11-S14
[4]   Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction [J].
Corbin, JD ;
Francis, SH ;
Webb, DJ .
UROLOGY, 2002, 60 (2B) :4-11
[5]   Potent inhibition of human phosphodiesterase-5 by icariin derivatives [J].
Dell'Agli, Mario ;
Galli, Gerrnana V. ;
Del Cero, Esther ;
Belluti, Federica ;
Matera, Riccardo ;
Zironi, Elisa ;
Pagliuca, Giampiero ;
Bosisio, Enrica .
JOURNAL OF NATURAL PRODUCTS, 2008, 71 (09) :1513-1517
[6]  
Department for Development of Thai Traditional and Alternative Medicine Ministry of Public Health, 2009, MON SEL THAI MAT MED, V1
[7]  
Federal Drug Administration, 2011, CIAL TAD PRESCR INF
[8]  
Federal Drug Administration, 2010, VIAGR SILD PRRSCR IN
[9]   Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons [J].
Ferguson, James E., III ;
Carson, Culley C., III .
ARAB JOURNAL OF UROLOGY, 2013, 11 (03) :222-229
[10]   Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase [J].
Huang, DM ;
Hinds, TR ;
Martinez, SE ;
Doneanu, C ;
Beavo, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :48143-48151